LPCN
Price
$8.16
Change
-$0.02 (-0.24%)
Updated
Feb 5, 02:58 PM (EDT)
Capitalization
45.75M
Intraday BUY SELL Signals
PRAX
Price
$301.62
Change
-$1.72 (-0.57%)
Updated
Feb 5, 03:35 PM (EDT)
Capitalization
8.41B
27 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LPCN vs PRAX

Header iconLPCN vs PRAX Comparison
Open Charts LPCN vs PRAXBanner chart's image
Lipocine
Price$8.16
Change-$0.02 (-0.24%)
Volume$200
Capitalization45.75M
Praxis Precision Medicines
Price$301.62
Change-$1.72 (-0.57%)
Volume$100
Capitalization8.41B
LPCN vs PRAX Comparison Chart in %
LPCN
Daily Signal:
Gain/Loss:
PRAX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
LPCN vs. PRAX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LPCN is a Hold and PRAX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (LPCN: $8.18 vs. PRAX: $303.34)
Brand notoriety: LPCN and PRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LPCN: 41% vs. PRAX: 69%
Market capitalization -- LPCN: $45.75M vs. PRAX: $8.41B
LPCN [@Biotechnology] is valued at $45.75M. PRAX’s [@Biotechnology] market capitalization is $8.41B. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LPCN’s FA Score shows that 0 FA rating(s) are green whilePRAX’s FA Score has 0 green FA rating(s).

  • LPCN’s FA Score: 0 green, 5 red.
  • PRAX’s FA Score: 0 green, 5 red.
According to our system of comparison, LPCN is a better buy in the long-term than PRAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LPCN’s TA Score shows that 3 TA indicator(s) are bullish while PRAX’s TA Score has 2 bullish TA indicator(s).

  • LPCN’s TA Score: 3 bullish, 5 bearish.
  • PRAX’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, LPCN is a better buy in the short-term than PRAX.

Price Growth

LPCN (@Biotechnology) experienced а -13.53% price change this week, while PRAX (@Biotechnology) price change was -2.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.81%. For the same industry, the average monthly price growth was -1.54%, and the average quarterly price growth was +30.06%.

Reported Earning Dates

PRAX is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (-5.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRAX($8.41B) has a higher market cap than LPCN($45.7M). PRAX YTD gains are higher at: 2.918 vs. LPCN (1.868). LPCN has higher annual earnings (EBITDA): -6.25M vs. PRAX (-292.95M). PRAX has more cash in the bank: 267M vs. LPCN (15.1M). PRAX has less debt than LPCN: PRAX (436K) vs LPCN (1.48M). PRAX has higher revenues than LPCN: PRAX (7.46M) vs LPCN (4.32M).
LPCNPRAXLPCN / PRAX
Capitalization45.7M8.41B1%
EBITDA-6.25M-292.95M2%
Gain YTD1.8682.91864%
P/E RatioN/AN/A-
Revenue4.32M7.46M58%
Total Cash15.1M267M6%
Total Debt1.48M436K340%
FUNDAMENTALS RATINGS
LPCN: Fundamental Ratings
LPCN
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LPCNPRAX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 17 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
LPCN
Daily Signal:
Gain/Loss:
PRAX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GVLU26.220.51
+1.99%
Gotham 1000 Value ETF
TYG44.440.30
+0.68%
Tortoise Energy Infrastructure Corp
GBPUSD1.37N/A
N/A
United Kingdom Pound - United States Dollar
AUDHKD5.49N/A
N/A
Australian Dollar - Hong Kong Dollar
CNYAUD0.21N/A
N/A
China Yuan - Australian Dollar

LPCN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LPCN has been closely correlated with PMN. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if LPCN jumps, then PMN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LPCN
1D Price
Change %
LPCN100%
-2.04%
PMN - LPCN
80%
Closely correlated
-1.57%
STRO - LPCN
79%
Closely correlated
+0.40%
PRAX - LPCN
79%
Closely correlated
-2.31%
ACET - LPCN
78%
Closely correlated
-3.51%
ANL - LPCN
77%
Closely correlated
+7.23%
More

PRAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRAX has been closely correlated with TERN. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if PRAX jumps, then TERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRAX
1D Price
Change %
PRAX100%
-2.31%
TERN - PRAX
87%
Closely correlated
-6.39%
ATOS - PRAX
87%
Closely correlated
-4.34%
STRO - PRAX
86%
Closely correlated
+0.40%
PMN - PRAX
86%
Closely correlated
-1.57%
ACET - PRAX
85%
Closely correlated
-3.51%
More